Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis

BackgroundAnticoagulation is essential during continuous renal replacement therapy (CRRT) for acute kidney injury to maintain circuit patency and balance bleeding risks.ObjectiveSystematically compare the anticoagulant efficacy and safety of nafamostat mesylate (NM) versus heparin in CRRT.MethodsWe...

Полное описание

Библиографические подробности

Главные авторы:	Yao Wang, Qiuhong He, Dan Wen, Rong Xu, Xiao Yu, Lingning Zhao
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-02-01
Серии:	Frontiers in Medicine
Предметы:	anticoagulation continuous renal replacement therapy heparin meta-analysis nafamostat mesylate
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1713412/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!